ampicillin has been researched along with Chronic Liver Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, T; Carpenter, I; Eguchi, S; Hara, T; Hidaka, M; Kinoshita, A; Kitasato, A; Kuroki, T; Soyama, A; Takatsuki, M | 1 |
| Hoyer, DP; Juntermanns, B; Kaiser, GM; Manka, P; Mathé, Z; Pracht, W; Radunz, S; Rath, PM; Schulze, M; Steinmann, J; Treckmann, JW | 1 |
2 other study(ies) available for ampicillin and Chronic Liver Failure
| Article | Year |
|---|---|
The impact of treated bacterial infections within one month before living donor liver transplantation in adults.
Topics: Adult; Aged; Ampicillin; Anti-Bacterial Agents; Bacterial Infections; Cefazolin; Drug Therapy, Combination; End Stage Liver Disease; Female; Humans; Incidence; Liver Transplantation; Living Donors; Male; Middle Aged; Perioperative Care; Postoperative Complications; Preoperative Period; Retrospective Studies; Risk Factors; Survival Analysis; Treatment Outcome | 2014 |
Infectious complications in the era of MELD.
Topics: Adult; Ampicillin; Anti-Bacterial Agents; Antibiotic Prophylaxis; End Stage Liver Disease; Female; Graft Survival; Humans; Incidence; Liver Transplantation; Male; Middle Aged; Pneumonia; Retrospective Studies; Sepsis; Severity of Illness Index; Sulbactam; Treatment Outcome | 2015 |